4.6 Article

Pirfenidone prevents esophageal stricture by inhibiting nucleotide binding oligomerization domain like receptor protein 3 inflammasome activation

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Role of nucleotide binding oligomerization domain-like receptor protein 3 inflammasome in stress-induced gastric injury

Akira Higashimori et al.

Summary: The study revealed that NLRP3 inflammasome-derived IL-1 beta plays a protective role in stress-induced gastric injury through activation of the COX-2/PGE(2) axis. Toll-like receptor 4 signaling and gastric acid may be involved in NLRP3 inflammasome activation.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Pharmacology & Pharmacy

Pirfenidone is a renal protective drug: Mechanisms, signalling pathways, and preclinical evidence

Xue Bai et al.

Summary: Renal fibrosis, a characteristic of all chronic kidney diseases, currently lacks effective therapeutic drugs. Pirfenidone (PFD), widely used in idiopathic pulmonary fibrosis, exerts anti-fibrotic, anti-inflammatory, antioxidant, and anti-apoptotic effects attributed to the suppression of cell growth factors and other pathways. With similar anti-fibrotic pathways in lung and kidney diseases, PFD has shown promising results in improving the treatment of renal fibrotic disease.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Review Pharmacology & Pharmacy

Targeting the NLRP3 inflammasome to treat cardiovascular fibrosis

Anita A. Pinar et al.

PHARMACOLOGY & THERAPEUTICS (2020)

Review Medicine, General & Internal

Ingestion of Caustic Substances

Robert S. Hoffman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Gastroenterology & Hepatology

Silicone-covered biodegradable magnesium stent for treating benign esophageal stricture in a rabbit model

Kai Yang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

Review Gastroenterology & Hepatology

Prevention of esophageal stricture after endoscopic resection

Ryu Ishihara

DIGESTIVE ENDOSCOPY (2019)

Article Gastroenterology & Hepatology

Activation of Myofibroblast TRPA1 by Steroids and Pirfenidone Ameliorates Fibrosis in Experimental Crohn's Disease

Lin Hai Kurahara et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Single Locoregional Triamcinolone Injection Immediately After Esophageal Endoscopic Submucosal Dissection Prevents Stricture Formation

Yasuaki Nagami et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2017)

Article Gastroenterology & Hepatology

NOD-Like Receptor Protein 3 Inflammasome Priming and Activation in Barrett 's Epithelial Cells

Yuji Nadatani et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Endoscopic submucosal dissection

John T. Maple et al.

GASTROINTESTINAL ENDOSCOPY (2015)

Article Surgery

Pirfenidone prevents rat esophageal stricture formation

J. Orozco-Perez et al.

JOURNAL OF SURGICAL RESEARCH (2015)

Review Medicine, General & Internal

Fibrosis - A Common Pathway to Organ Injury and Failure

Don C. Rockey et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Gastroenterology & Hepatology

Effects of tenoxicam in experimental corrosive esophagitis model

M. Erbas et al.

DISEASES OF THE ESOPHAGUS (2015)

Article Biochemical Research Methods

NIH Image to ImageJ: 25 years of image analysis

Caroline A. Schneider et al.

NATURE METHODS (2012)

Article Respiratory System

Pirfenidone in idiopathic pulmonary fibrosis

H. Taniguchi et al.

EUROPEAN RESPIRATORY JOURNAL (2010)